| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Takahiro Masuda, Fuminari Misawa, Masayuki Takase, John M Kane, Christoph U Correl. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. JAMA psychiatry. vol 76. issue 10. 2021-01-21. PMID:31365048. |
association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies. |
2021-01-21 |
2023-08-13 |
Not clear |
| Takahiro Masuda, Fuminari Misawa, Masayuki Takase, John M Kane, Christoph U Correl. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. JAMA psychiatry. vol 76. issue 10. 2021-01-21. PMID:31365048. |
recent meta-analyses of randomized clinical trials (rcts) comparing clozapine with nonclozapine second-generation antipsychotics (nc-sgas) in schizophrenia have challenged clozapine's superiority in treatment-resistant patients. |
2021-01-21 |
2023-08-13 |
Not clear |
| Hein Bokern, Niels Jonker, Dan Cohe. Creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open. vol 7. issue 1. 2021-01-16. PMID:33272348. |
creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. |
2021-01-16 |
2023-08-13 |
Not clear |
| Hein Bokern, Niels Jonker, Dan Cohe. Creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open. vol 7. issue 1. 2021-01-16. PMID:33272348. |
in forensic settings, the most common indication for clozapine is treatment-resistant schizophrenia (trs). |
2021-01-16 |
2023-08-13 |
Not clear |
| Hein Bokern, Niels Jonker, Dan Cohe. Creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open. vol 7. issue 1. 2021-01-16. PMID:33272348. |
clozapine has also been shown to be effective in reducing hostility, aggression and violence in patients with schizophrenia and is of benefit in comorbid substance use disorders. |
2021-01-16 |
2023-08-13 |
Not clear |
| Juan Andrés Martínez-Andrés, Juan Antonio García-Carmon. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. International clinical psychopharmacology. vol 35. issue 3. 2021-01-13. PMID:31851035. |
switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. |
2021-01-13 |
2023-08-13 |
Not clear |
| Juan Andrés Martínez-Andrés, Juan Antonio García-Carmon. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. International clinical psychopharmacology. vol 35. issue 3. 2021-01-13. PMID:31851035. |
clozapine, an antipsychotic developed in 1958, is considered the gold standard and the treatment of choice in treatment-resistant schizophrenia despite its side effects and despite 40-70% of these patients not responding to clozapine. |
2021-01-13 |
2023-08-13 |
Not clear |
| Juan Andrés Martínez-Andrés, Juan Antonio García-Carmon. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. International clinical psychopharmacology. vol 35. issue 3. 2021-01-13. PMID:31851035. |
the aim of our study was to carry out an exploratory evaluation of endocrine and hepatic profiles as well as the concomitant treatments associated to pp3m vs. clozapine, the gold standard, in patients with treatment-resistant schizophrenia. |
2021-01-13 |
2023-08-13 |
Not clear |
| Juan Andrés Martínez-Andrés, Juan Antonio García-Carmon. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort. International clinical psychopharmacology. vol 35. issue 3. 2021-01-13. PMID:31851035. |
more studies are needed to truly establish the role of pp3m in treatment-resistant schizophrenia and should be compared against clozapine by using clinical trials. |
2021-01-13 |
2023-08-13 |
Not clear |
| Sandeep Grover, Meha Verma, Subho Chakrabart. Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32195772. |
safety of use of clozapine in patients with schizophrenia with comorbid diabetes mellitus. |
2021-01-13 |
2023-08-13 |
Not clear |
| Sandeep Grover, Meha Verma, Subho Chakrabart. Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32195772. |
to evaluate the outcome of diabetes mellitus among patients of schizophrenia who had diabetes mellitus before starting clozapine. |
2021-01-13 |
2023-08-13 |
Not clear |
| Herbert Y Meltzer, Daniel B Share, Karu Jayathilake, Ronald M Salomon, Myung A Le. Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32332459. |
in addition to clozapine, other atypical antipsychotic drugs pharmacologically similar to clozapine, for example, olanzapine, risperidone, and melperone, are also effective in a similar proportion of treatment-resistant schizophrenia (trs) patients, ~40%. |
2021-01-13 |
2023-08-13 |
Not clear |
| Maxim Kuzin, Benjamin Bochon, Efstratios Vagiaris, Gerhard Dammann, Gerhard Gründer, Michael Paulzen, Georgios Schoretsaniti. Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32332469. |
changes in clozapine bioavailability in a percutaneous endoscopic gastrostomy-fed patient with treatment-resistant schizophrenia. |
2021-01-13 |
2023-08-13 |
Not clear |
| Naveen M, Amol N Patil, Smita Pattanaik, Anit Kaur, Dibyajyoti Banerjee, Sandeep Grove. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. Asian journal of psychiatry. vol 48. 2021-01-11. PMID:31896438. |
abcb1 and drd3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in asian indian treatment resistant schizophrenia patients. |
2021-01-11 |
2023-08-13 |
Not clear |
| Naveen M, Amol N Patil, Smita Pattanaik, Anit Kaur, Dibyajyoti Banerjee, Sandeep Grove. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. Asian journal of psychiatry. vol 48. 2021-01-11. PMID:31896438. |
to investigate association of two single nucleotide polymorphisms (snps) abcb1(rs1045462) and drd3(rs6280) with clozapine response and the dose in treatment resistant schizophrenia (trs) patients. |
2021-01-11 |
2023-08-13 |
Not clear |
| J Y K Poon, D Y Y Tang, B W M Siu, S H Lu. Elevated Clozapine Level Following Acute Infection in a Patient with Schizophrenia: a Case Report. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. vol 30. issue 4. 2021-01-11. PMID:33349619. |
elevated clozapine level following acute infection in a patient with schizophrenia: a case report. |
2021-01-11 |
2023-08-13 |
Not clear |
| J Y K Poon, D Y Y Tang, B W M Siu, S H Lu. Elevated Clozapine Level Following Acute Infection in a Patient with Schizophrenia: a Case Report. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. vol 30. issue 4. 2021-01-11. PMID:33349619. |
we describe a 58-year-old chinese man with schizophrenia who presented with an elevated clozapine level suspected to be related to acute infection. |
2021-01-11 |
2023-08-13 |
Not clear |
| Mehran Zarghami, Seyed Davood Hoseini, Arash Kazemi, Forouzan Elyas. Concurrent Hepatotoxicity and Neutropenia Induced by Clozapine. Archives of Iranian medicine. vol 23. issue 2. 2021-01-06. PMID:32061077. |
clozapine is known as one of the atypical antipsychotics which is placed in the second line of medical treatment for schizophrenia due to its hematologic complications. |
2021-01-06 |
2023-08-13 |
Not clear |
| Mehran Zarghami, Seyed Davood Hoseini, Arash Kazemi, Forouzan Elyas. Concurrent Hepatotoxicity and Neutropenia Induced by Clozapine. Archives of Iranian medicine. vol 23. issue 2. 2021-01-06. PMID:32061077. |
the patient was a 58-year-old man who started taking clozapine for the first time in march 2017, about seven weeks before his recent admission, because of a history of treatment-resistant schizophrenia. |
2021-01-06 |
2023-08-13 |
Not clear |
| T Scott Strou. Clozapine and Evidence-Based Psychopharmacology for Schizophrenia. JAMA psychiatry. vol 76. issue 10. 2021-01-04. PMID:31365031. |
clozapine and evidence-based psychopharmacology for schizophrenia. |
2021-01-04 |
2023-08-13 |
Not clear |